These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. [New effects of antimicrobial agents other than antimicrobial activity]. Hirata N; Hiramatsu K; Kadota J; Nasu M Nihon Rinsho; 2003 Feb; 61 Suppl 2():819-24. PubMed ID: 12722322 [No Abstract] [Full Text] [Related]
28. Possible interaction involving phenytoin, dexamethasone, and antineoplastic agents: a case report and review. Gattis WA; May DB Ann Pharmacother; 1996 May; 30(5):520-6. PubMed ID: 8740335 [TBL] [Abstract][Full Text] [Related]
29. [The effect of intravenous ciprofloxacin for community acquired pneumonia in adults]. Fujita M; Ishibashi T; Hara N; Yoshida M; Yamada H; Jpn J Antibiot; 2003 Aug; 56(4):289-93. PubMed ID: 14567253 [TBL] [Abstract][Full Text] [Related]
30. Inadvertent use of ciprofloxacin as a single agent in undiagnosed tuberculosis. Khilnani G; Gupta RC J Assoc Physicians India; 1998 Apr; 46(4):401. PubMed ID: 11273333 [No Abstract] [Full Text] [Related]
31. Fosphenytoin in infants. Takeoka M; Krishnamoorthy KS; Soman TB; Caviness VS J Child Neurol; 1998 Nov; 13(11):537-40. PubMed ID: 9853645 [TBL] [Abstract][Full Text] [Related]
32. Probable metabolic interaction of doxifluridine with phenytoin. Konishi H; Morita K; Minouchi T; Nakajima M; Matsuda M; Yamaji A Ann Pharmacother; 2002 May; 36(5):831-4. PubMed ID: 11978162 [TBL] [Abstract][Full Text] [Related]
33. [The use of Ciprobay in the infectious complications of traumatic illness]. Ivanov RN Voen Med Zh; 1997 Jun; 318(6):49-51. PubMed ID: 9412064 [No Abstract] [Full Text] [Related]
34. Lower phenytoin serum levels in persons switched from brand to generic phenytoin. Stetz SA Neurology; 2005 Aug; 65(4):657-8; author reply 657-8. PubMed ID: 16118861 [No Abstract] [Full Text] [Related]
35. Possible drug interaction in chronic treatment of epileptic patients: serum level studies. Baraczka K; Molnár G Monogr Neural Sci; 1980; 5():235-9. PubMed ID: 7322158 [No Abstract] [Full Text] [Related]
36. Phenytoin removal during plasma exchange. White RL; Garnett WR; Allen JH; Kline BJ; Sharp DE J Clin Apher; 1987; 3(3):147-50. PubMed ID: 3558337 [TBL] [Abstract][Full Text] [Related]
37. Enteric fever treatment failures: a global concern. Chandel DS; Chaudhry R Emerg Infect Dis; 2001; 7(4):762-3. PubMed ID: 11585550 [No Abstract] [Full Text] [Related]
38. Antibacterial activity of ciprofloxacin-beta-cyclodextrin complex and its efficacy in dental implants. Aithal KS; Udupa N; Varma BR; Kurian R Indian J Dent Res; 1995; 6(4):123-8. PubMed ID: 9495116 [TBL] [Abstract][Full Text] [Related]
39. Safety, Tolerability, and Pharmacokinetics of Fosphenytoin Loading in Patients With Subarachnoid Hemorrhage. Kim DW; Kim TE; Ji M; Chun YI Clin Neuropharmacol; 2015; 38(6):248-51. PubMed ID: 26536021 [TBL] [Abstract][Full Text] [Related]
40. [A case of toxicity caused by drug interaction between capecitabine and phenytoin in patient with colorectal cancer]. Sakurai M; Kawahara K; Ueda R; Fukui E; Yamada R Gan To Kagaku Ryoho; 2011 May; 38(5):841-3. PubMed ID: 21566450 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]